Literature DB >> 2925509

New products related to kinamycin from Streptomyces murayamaensis. I. Taxonomy, production, isolation and biological properties.

M C Cone1, P J Seaton, K A Halley, S J Gould.   

Abstract

Six new products of Streptomyces murayamaensis sp. nov. Hata et Ohtani, the producer of the kinamycins, were isolated by silica gel column chromatography. The antibacterial activities of the new products, as well as that of dehydrorabelomycin and murayaquinone, previously isolated products of the same organism, were compared to the kinamycins. Three of the products had antibacterial activities similar to the kinamycins, while two others had activity only against Gram-positive bacteria. Dehydrorabelomycin and one other metabolite had no detectable antibacterial activity. The organism was found to be capable of aerial mycelium formation, with sporophores branched at regular intervals bearing square-ended spores with smooth surfaces. The culture contains L,L-diaminopimelic acid in the cell wall (Type I), is highly resistant to lysozyme, and lecithinase- and melanin-positive, suggesting a relationship with the genus Streptoverticillium and the lavendulae group of the genus Streptomyces.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2925509     DOI: 10.7164/antibiotics.42.179

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  13 in total

1.  Asymmetric total synthesis of the epoxykinamycin FL-120 B'.

Authors:  Stephen S Scully; John A Porco
Journal:  Angew Chem Int Ed Engl       Date:  2011-08-30       Impact factor: 15.336

2.  Production of Stealthin C Involves an S-N-Type Smiles Rearrangement.

Authors:  Peng Wang; Gloria J Hong; Matthew R Wilson; Emily P Balskus
Journal:  J Am Chem Soc       Date:  2017-02-16       Impact factor: 15.419

3.  The Mechanism of Action of (-)-Lomaiviticin A.

Authors:  Seth B Herzon
Journal:  Acc Chem Res       Date:  2017-09-28       Impact factor: 22.384

4.  Structural basis for DNA cleavage by the potent antiproliferative agent (-)-lomaiviticin A.

Authors:  Christina M Woo; Zhenwu Li; Eric K Paulson; Seth B Herzon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

5.  Analysis of diazofluorene DNA binding and damaging activity: DNA cleavage by a synthetic monomeric diazofluorene.

Authors:  Christina M Woo; Nihar Ranjan; Dev P Arya; Seth B Herzon
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-09       Impact factor: 15.336

6.  Discovery of the lomaiviticin biosynthetic gene cluster in Salinispora pacifica.

Authors:  Jeffrey E Janso; Brad A Haltli; Alessandra S Eustáquio; Kerry Kulowski; Abraham J Waldman; Li Zha; Hitomi Nakamura; Valerie S Bernan; Haiyin He; Guy T Carter; Frank E Koehn; Emily P Balskus
Journal:  Tetrahedron       Date:  2014-07-08       Impact factor: 2.457

7.  Multigram Synthesis of 1-O-Acetyl-3-O-(4-methoxybenzyl)-4-N-(9-fluorenylmethoxycarbonyl)-4-N-methyl-L-pyrrolosamine.

Authors:  Matthew Burk; Nolan Wilson; Seth B Herzon
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

8.  Cloning and heterologous expression of the entire gene clusters for PD 116740 from Streptomyces strain WP 4669 and tetrangulol and tetrangomycin from Streptomyces rimosus NRRL 3016.

Authors:  S T Hong; J R Carney; S J Gould
Journal:  J Bacteriol       Date:  1997-01       Impact factor: 3.490

9.  Development of enantioselective synthetic routes to (-)-kinamycin F and (-)-lomaiviticin aglycon.

Authors:  Christina M Woo; Shivajirao L Gholap; Liang Lu; Miho Kaneko; Zhenwu Li; P C Ravikumar; Seth B Herzon
Journal:  J Am Chem Soc       Date:  2012-10-03       Impact factor: 15.419

10.  Mechanism of the cytotoxicity of the diazoparaquinone antitumor antibiotic kinamycin F.

Authors:  Kimberley A O'Hara; Xing Wu; Daywin Patel; Hong Liang; Jack C Yalowich; Nan Chen; Valerie Goodfellow; Otunola Adedayo; Gary I Dmitrienko; Brian B Hasinoff
Journal:  Free Radic Biol Med       Date:  2007-07-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.